Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR-3.4%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-3.4%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 70.99% |
| 2024 | 46.33% |
| 2023 | -7.36% |
| 2022 | -20.02% |
| 2021 | 37.53% |
| 2020 | 84.52% |
| 2019 | 32.02% |
| 2018 | 205.83% |
| 2017 | 2.97% |
| 2016 | -26.92% |